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Abstract The GALl I gene encodes an auxiliary transcription factor equired for full expression of many, if not all, genes of the yeast Saccharomyces 
cerevisiae. We have recently shown that GALll-encoded protein (Galllp) enhances basal transcription from the CYC1 promoter in a cell-free 
transcription system [(1993) Proc. Natl. Acad. Sci. USA 90, 8382-8386]. Here we indicate that Gall 1 p stimulates basal transcription i a gene-specific 
manner in vitro. We further suggest hat the mechanism underlying the transcriptional stimulation by Gall I p is distinct from that by DNA-bound 
activators, since Gall lp stimulated transcription i  a reaction system where activators were unable to enhance transcription due to the lack of 
intermediary factors. 
Key words: GAL l  1 protein; Basal transcription; Gene specificity; Intermediary factor; In vitro transcription; 
Saccharomyces cerevisiae 
1. Introduction 
Recent biochemical studies have revealed that regulated syn- 
thesis of eukaryotic mRNA involves numerous proteins in ad- 
dition to RNA polymerase II. These proteins can be classified 
into at least three distinctive groups. The first group is a set of 
proteins called basal transcription factors which form a preini- 
tiation complex together with RNA polymerase II on the so- 
called core promoter comprising the TATA box and the initia- 
tion site [1,2]. The second class, referred to as activators in this 
report, consists of proteins that bind DNA in a most gene- 
specific fashion by recognizing specific DNA sequences, the 
enhancer or upstream activation sequence (UAS) [3]. The third 
class can be categorized as intermediary factors which mediate 
the activation signal of an activator(s) to the preinitiation com- 
plex [1,4]. In the yeast Saceharomyces erevisiae, cell-free tran- 
scription has been reconstituted with basal transcription factors 
designated a, b, d, e, and g by the studies of Kornberg and his 
associates [5-7]. They further demonstrated that the activator- 
induced transcription requires two additional intermediary fac- 
tors including a mediator [8,9] and a protein(s) contained in 
so-called fraction c [5,10]. 
The regulatory gene GAL l l  [11], also named SPT13 [12], of 
S. cerevisiae was first identified in a weak fermentor of galac- 
tose, and later found to encode a global transcription factor 
exerting its function on the expression of many genes [13]. 
Molecular genetic experiments had once suggested that Gal l  1 p 
was one of the intermediary factors for various activators, such 
as Gal4p, Grf lp,  or Ppr lp [14,15]. Later, we showed that 
GAL l l  is required for efficient basal transcription from the 
core promoter of CYC1 in yeast [16]. We also revealed that 
Gal l  lp does not bind to a specific DNA sequence but stimu- 
lates in vitro transcription from the CYC1 core promoter in the 
presence or absence of activators which include GAL4-VPI6, 
GAL4-AH, and Grflp. We further suggested that the apparent 
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potentiation of the activators by Gal l  lp was accounted for by 
the stimulation of basal transcription, and that the stimulation 
occurs at the step of preinitiation complex formation [16]. In 
this paper, we addressed the question why normal functioning 
of GAL l l  is required for full expression of many but not all the 
yeast genes in the cell. Here we demonstrate that the gene- 
specific transcriptional stimulation by Gal l  1 p depends on core 
promoters but not on UASs/activators. We also suggest hat 
the mechanism of transcriptional enhancement by Ga l l lp  is 
distinct from that by DNA-bound activators. In the light of 
these results we suggest hat Gal l  lp is a novel class transcrip- 
tion factor which regulates the efficiency of transcription initi- 
ation through interaction with basal transcription factors in a 
gene-specific manner. 
2. Materials and methods 
2.1. Template DNAs for in vitro transcription 
pSK119 [16] contained a single copy of a Gal4p-binding sequence 
(UASG) upstream of the CYC1 promoter/G-free cassette fusion, such 
that the distance between UAS G and the TATA box became 29-base 
pairs. The UAS-less template pSK115 was described previously [16]. 
pSK145 was constructed as follows: Plasmid pMT24-271 containing 
the GAL7 gene [17] was digested with MboII which cleaves GAL7 DNA 
at nucleotide position +43 with respect o the transcription i itiation 
site at + 1 [18]. After the ends were blunt-ended by T4 DNA polymerase, 
the BamH1-MbolI fragment (position from -271 to +43) was cloned 
into the BamH 1 and SmaI sites of pSK 140, a derivative of pUC 118 with 
modification at the Sac! site which had been converted to Bglll site. 
pSK164 containing the core promoter of GAL7 was constructed as 
follows: pSK145 was digested with NheI (position -73), blunt-ended by 
mung bean nuclease, and digested with BglII. The liberated fragment 
containing the core promoter of GAL7 was cloned into the SmaI and 
Bglll sites of pSK140, pSKI61 containing the GAL80 gene was con- 
structed by subcloning of the DraI-BglII fragment (position from -218 
to +83 [19]) into the SmaI and BgllI sites of pSKI42, a derivative of 
pUC119 with the same modification as pSK140. 
2.2. Preparation of transcription factors and extracts 
Yeast Gall lp and recombinant GAL4-VPI6 were purified as de- 
scribed [16]. Recombinant yeast TATA-binding protein (TBP) pro- 
duced in Escherichia coli was a kind gift from H. Handa. Yeast nuclear 
extract was prepared from galll null strain HS301 as described [16]. 
Yeast fractionated whole cell extract was prepared from HS301 as 
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described [10], and the final sample was dialyzed against buffer A 
containing 50 mM potassium acetate [5]. Fraction c' was prepared from 
nuclear extract of strain BJ2168, a GALl1 wild-type derivative of 
HS301, exactly as fraction c [5], except hat the heat treatment was 
omitted (the heat treatment abolished the activity in our preparation 
possibly because of the difference in strain). 
2.3. In vitro transcription 
The transcription assay using the yeast nuclear extract was carried 
out as described previously [16] except hat the reaction was performed 
at 25°C for 90 rain. The whole cell extract ranscription system con- 
tained the fractionated whole cell extract (9 pg of protein), TBP (50 ng 
of protein) and 80 ng of template DNA in the same buffer as in the 
nuclear extract ranscription system. The reactions were carried out in 
the presence or absence of 6 ng of Galllp. When transcripts were 
analyzed by primer extension or S1 nuclease mapping, the reaction 
mixture contained 0.4 mM of each of the four ribonucleoside tri- 
phosphates. In the case of primer extension analysis, the reaction was 
terminated by the addition of 0.2 ml of a stop solution (0.3 M sodium 
acetate pH 5.2, 0.5% SDS, 5 mM EDTA and 20 pg of proteinase K) 
and incubated at 30°C for 20 min. Nucleic acids were extracted through 
two cycles of phenol/chloroform (1 : 1) treatment and precipitated by the 
addition of 2.5 volumes of ethanol. The pellet was dissolved in 12 pl 
of an annealing buffer (10 mM Tris-HC1 pH 8.0, 1 mM EDTA and 175 
mM KC1) containing 60 fmol of Y-end-labeled RV primer (Takara 
Shuzo, Kyoto, Japan). After incubation at 37°C for 1 h, the reaction 
mixture was diluted with 18/.tl of a reverse transcription buffer (83 mM 
Tris-HC1 pH 8.0, 16.8 mM dithiothreitol, 16.8 mM MgC12 and 833/.tM 
of each of the four deoxyribonucleoside triphosphates) containing 3 U 
of Rous associated virus 2 reverse transcriptase. After incubation at 
37°C for 40 rain, primer extension products were recovered by ethanol 
precipitation and analyzed on a 8% polyacrylamide/7 M urea gel. 
GAL80 transcripts were analyzed by S1 nuclease mapping. The tran- 
scription reaction was terminated by the addition of 5/.tg of DNase I 
and 2 pg of tRNA. After incubation at 25°C for 10 min, samples were 
treated with the stop solution, and nucleic acids were recovered as 
above. SI nuclease mapping was performed as described [20]. Probe 
DNA was the BglII-PstI fragment of pSK161 with 5'-end label at the 
BglII site (position +88). Fragments protected from S1 nuclease diges- 
tion were separated on a 8% polyacrylamide/7 M urea gel. 
3. Results 
3.1. Gene-specific enhancement of transcription by Gall lp 
Previously we showed that normal functioning of GALl l  is 
required for the efficient ranscription of GALl, GAL2, GAL7 
or GALIO but not of GAL80 in yeast cells [11,13], despite the 
fact that all these genes are under the control of GaI4p/UAS~ 
[21]. To investigate what determines the gene-specificity of 
GALl l  function, we analyzed the effect of Gal l  lp on transcrip- 
tion of the GAL7 and GAL80 genes in a cell-free system (Fig. 
1A). Fragments from -271 to +43 of GAL7 or from -218 to 
+83 of GAL80 were subcloned into plasmids and used as tem- 
plates. When the in vitro transcripts of GAL7 were analyzed by 
primer extension, transcription was initiated at +1 and +28 
(lane 1). Addition of GAL4-VP16 resulted in a 10-fold activa- 
tion of transcription (lane 3), since this template has two UASa 
[17]. Ga l l lp  enhanced both basal and GAL4-VP16-activated 
transcription by a factor 4. The apparent potentiation of 
GAIA-VP16 by Ga l l lp  is attributable to the stimulation of 
basal transcription as described previously [16]. In case of  
GAL80, the transcripts were analyzed by the S1 nuclease map- 
ping technique. As shown in lane 1 of Fig. 1 B, transcription of 
GAL80 was initiated at +5 in vitro. Transcription from +5 was 
also detected in vivo transcripts (lane M). GAIA-VP16 acti- 
vated transcription from +1, +5 and +37 (lane 3) by binding 
to the UAS~ lying at -95 [22]. In contrast to the case of GAL7, 
addition of Gal l  lp to the reaction did not cause a significant 
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Fig. 1. Gene-speeific stimulation by Gall lp. (A) Transcription of 
GAL7. The template DNA pSKI45 was transcribed in vitro, and the 
transcripts were analyzed by primer extension. The reaction mixture 
contained Gall lp (lanes 2 and 4) and/or 0.5 pmol of GAL4-VP16 
(lanes 3 and 4). Positions of the initiation sites are indicated to the right 
of the panel with respect o the transcription i itiation site at +1 [18]. 
(B) Transcription of GAL80. The template DNA pSKI61 was tran- 
scribed, and the transcripts were analyzed by S 1 nuclease mapping. The 
reaction mixture contained Gall lp (lanes 2 and 4) and/or 0.5 pmol of 
GAL4-VPI6 (lanes 3 and 4). The total RNA (10gg) prepared from the 
wild-type yeasts (HSY5-3C [16]) grown in YPGal [13] was subjected by 
SI mapping, and the protected fragments were co-electrophoresed to 
verify the initiation site of GAL80 (lane M). Positions of the initiation 
sites are indicated to the right of the panel with respect o the transrip- 
tion initiation site at +1 [19]. (C) Transcription of core promoter of 
GAL7. The template DNA pSK 164 was transcribed inthe absence (lane 
1) or presence (lane 2) of Gall l p, and the transcripts were analyzed by 
primer extension. The transcription i itiation sites are indicated to the 
right as A. 
stimulatory effect on transcription of GAL80 (lanes 2 and 4). 
We concluded therefore that transcriptional stimulation by 
Gal l  lp observed in vitro faithfully reflects the GALl l  function 
in vivo. Similarly to the case of the entire GAL7 promoter 
(regulatory) region, transcription from a template containing 
the core promoter of GAL7 spanning from -69 to +43 (the 
TATA box is located at -63 [17]) was also stimulated by Gal l  lp 
(Fig. 1C). This result suggests that Gal l  lp exerted its effect on 
the basal transcription in a gene-specific fashion presumably 
depending on the core promoter context. 
3.2. Non-involvement of intermediary factors in Gall lp 
function 
Previously, Himmelfarb et al. [15] demonstrated that Gal 11 p, 
when tethered to upstream region of a reporter gene through 
the DNA-binding domain of LexAp, functions as a potent 
DNA-bound activator in yeast. This result might be interpreted 
to imply that Gal 11 p stimulates transcription through the same 
pathway as DNA-bound activators. It has been known that the 
activators like GAL4-VPI6 and Gcn4p require at least two 
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intermediary factors for their activation function in the yeast 
cell-free transcription system. The one termed mediator is a 
protein that relieves squelching interference caused by excess 
amounts of activator proteins [4,8,9]. The other protein(s) is 
contained in fraction c, which was separated from the yeast 
nuclear extract by DEAE and phosphocellulose chromatogra- 
phy [5,10]. Thus we investigated whether these factors were 
required for transcriptional stimulation by Gall lp. As shown 
in Fig. 2, transcription of a template containing UAS~ was 
activated by the addition of 1 pmol of GAL4-VPI6 (lane 5). 
However, addition of an excess amount of GAL4-VP16 (40 
pmol) resulted in no activation. Instead, the amount of tran- 
scripts decreased to the basal level, presumably due to the 
squelching [4] of mediator by GAL4-VPI6 (compare lanes 3 
and 6). It was reported that addition of an excess amount of 
GAL4-VP16 in the reaction mixture inhibits basal transcrip- 
tion, which is a phenomenon called cis-inhibition [23]. In the 
present experiment, however, basal transcription was not af- 
fected as hown in lane 2, possibly because the concentration 
of template DNA was relatively low [23]. In the presence of 
excess GAL4-VP16, Gal l lp  still enhanced transcription by a 
factor 4 (lane 7). It was unlikely that this stimulation was due 
to release from the squelching inhibition, since the fold en- 
hancement by Gal 11 p was the same irrespective of the absence 
or presence of excess GAL4-VP16 (compare lanes 4 and 7). 
Therefore these results suggested hat the mediator for GAL4- 
VP16 was not involved in transcriptional stimulation by 
Gall lp. 
We further studied the requirement of fraction c for stimula- 
tion by Gall lp using the transcription system derived from 
yeast whole cell extract [10]. In this system, basal transcription 
was reconstituted by the addition of TATA-binding protein 
(TBP). When activators like GAL4-VP16 or Gcn4p were in- 
cluded in the reaction, an additional factor(s) in fraction c was 
required for their activation function [10]. As shown in Fig. 3A, 
basal transcription was reconstituted by the addition of TBP 
to the fractionated extract prepared from the gall1 null yeasts 
(lane 2). The Gall lp fraction could not substitute for the TBP 
activity (lane 3). In the presence of TBP, Gall lp induced tran- 
scription by a factor 6 over the basal level (lane 4) under condi- 
tions in which GAL4-VP16 could not activate transcription 
t . lAS4ess MASG 
GAL4-VP16 0 40  0 0 1 40  40prnot  
GAL l1  - -  - -  - -I- - - -  -!- 
1 2 3 4 5 6 7  
Fig. 2. Transcriptional stimulation by Gall lp under squelching condi- 
tion. The UAS-less template pSK115 (lanes 1 and 2) or UASc-inserted 
template pSK119 (lanes 3 7) was transcribed inthe absence (lanes 1, 
3 and 4) or presence of 1 pmol (lane 5)or 40 pmol (lanes 2,6 and 7) 
of GAL4-VP16. Galllp was also added to the reaction (lane 4 and 7). 
A 
TBP- -  + - -  + + + 
GAL4-VP16 + + 
GAL l1  + + - -  + 
1 2 3 4 5 6 
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fraclionc' + + + + + + _ _ 
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Fig. 3. Gall ip stimulates basal transcription n transcription system 
using fractionated whole cell extract. (A) Template DNA pSK119 was 
transcribed in the fractionated whole cel  xtract. Recombinant yeast 
TBP was added to the reactions (lanes 2, 4, 5 and 6). The reactions also 
contained Gall lp (lanes 3, 4 and 6) and/or 0.5 pmol of GAL4-VP16 
(lanes 5 and 6). (B) Transcription reactions were carried out in the 
presence ofTBE Gall lp was added to the reactions (even numbered 
lanes). The reactions included fraction c' (10/lg of protein, lanes 5 10) 
and 0.5 pmol (lanes 3,4, 7 and 8) or 15 pmol (lanes 9-12) of GAL4- 
VP16. 
(lane 5). In other words, Gall lp but not GAL4-VP16 stimu- 
lated transcription i a system composed of the fractionated 
whole cell extract and TBP. The Gall lp-induced transcription 
was further enhanced by GAL4-VP16 by 2- to 3-fold (compare 
lanes 4 and 6 of Fig. 3A or lanes 2 and 4 of Fig. 3B). The 
meaning of this enhancement remains unknown at this mo- 
ment. To reconstitute he transcription system which responds 
to GAL4-VP16, fraction c' was prepared from yeast nuclear 
extract (Fig. 3B). Fraction c' was not strictly the same as the 
original fraction c [5], since the heat treatment was omitted for 
the present preparation (see section 2). In agreement with the 
published result [10], GAL4-VP16 activated transcription by 
approximately 5-fold in the presence of fraction c' (compare 
lanes 3 and 7). As in the experiments with nuclear extract [16], 
Gall lp further enhanced the GAL4-VP16-activated transcrip- 
tion (lane 8). The transcriptional ctivation by GAL4-VP16 
was not observed when excess amount of GAL4-VP16 was 
added, presumably due to the squelching of mediator as above. 
Under such conditions, Gall lp enhanced transcription (la e 
10). Furthermore, in the absence of fraction c' and in the pres- 
ence of excess GAL4-VP 16, Gal 11 p stimulated transcription by 
approximately 5-fold, which is the same fold enhancement as 
by Gall lp alone (compare lanes 2 and 12). These results indi- 
cated that Gall lp required neither mediator nor fraction c' for 
its function, suggesting that the mechanism of transcriptional 
stimulation by Gal l lp  was inherently different from that by 
activators uch as GAL4-VP16 or Gcn4p. 
4. D iscuss ion  
We have revealed a couple of new features of Gall lp as a 
distinctive type transcription factor. First, the stimulatory ef- 
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fect of Gal 1 lp on the basal transcription appears to be specific 
for the core promoter. Thus Gall lp enhances basal as well as 
activated transcription from the core promoters of CYC1 [16] 
or GAL7 but not from GAL80. Importantly, the in vitro spec- 
ificity parallels with t e GALll-dependency of a gene in vivo. 
Second, Gall lp enhances basal transcription i the absence of 
mediator or a protein(s) in fraction c (strictly c'), both of which 
are required for activated transcription by DNA-bound activa- 
tors, such as GAL4-VP16 or Gcn4p [8-10]. These results indi- 
cate that Gall lp does not require such intermediary factors for 
its function and stimulates transcription through a pathway 
different from that of activators. Although the exact mecha- 
nism of Gall lp function has remained to be elucidated, it is 
tempting to imagine that Gal l lp  interacts with a basal tran- 
scription factor(s) and that the formation of the preinitiation 
complex is regulated at multiple steps by activators and auxil- 
iary factors like Gall lp. In support of this view, we have previ- 
ously demonstrated that Gal 11 p was involved in the formation 
of the preinitiation complex [16]. In in vitro transcription sys- 
tems of mammalian origin, the requirement for the basal tran- 
scription factors has been found to vary in each promoter, 
suggesting that compositions of the basal factors in the preini- 
tiation complex are variable with promoter [24,25]. We may 
speculate therefore that Gall lp can interact with the preinitia- 
tion complex formed on the CYC1 or GAL7 promoters through 
a basal transcription factor but not with the complex formed 
on the GALSO promoter lacking that factor. 
Besides GALl1, a number of regulatory genes have been 
identified, in which mutations cause pleiotropic defects, which 
likewise appear to affect the expression of many genes. They 
include SWIs and SINs identified as regulatory genes for the 
HO gene, SNFs and SSNs for SUC2, and SPTs for transposa- 
ble elements, Ty or delta (reviewed in [26]). Interestingly, some 
of the mutants isolated through the different screening systems 
were identical, which were therefore given different ames. In 
fact, gall1 mutants were isolated as one of the spts (sptl3 [12]), 
and also as one of the snfs [27]. Successive studies have sug- 
gested that those genes encode ither transcription factors or 
proteins involved in chromatin structures. Thus SPT15 encodes 
for TBP, SPT11 and SPT12 for histones H2A and H2B, respec- 
tively, and SPT2/SIN1 for an HMG-like protein (reviewed in 
[26]). Here we describe the protein encoded by GAL11/SPT13 
as another xample of transcription factor equired for efficient 
basal transcription of some genes. 
Another group of global regulatory factors encoded by a set 
of genes designated SRB have been characterized genetically as 
well as biochemically. Those genes were identified as suppres- 
sors of partial truncation mutations of carboxyl terminal do- 
main (CTD) of the largest ubunit of RNA polymerase II [28]. 
Among those genes, SRB2 and SRB5, when disrupted, cause 
pleiotropic defects but not lethality in yeast as in the case of 
GALl1 [28-30]. In vitro transcription experiments have re- 
vealed the requirement of Srb2p and Srb5p for efficient ran- 
scription initiation [29,30]. They further indicated that the SRB 
proteins form a complex with RNA polymerase II and a set of 
basal transcription factors and the complex responses to activa- 
tors [31]. Most recently, Kim et al. [32] also isolated a complex 
form of RNA polymerase II, termed 'holoenzyme' of RNA 
polymerase II, from the fractionated whole cell extract. This 
complex comprised some 20 polypeptides, including TFIIF, 
Gall lp, the SRB proteins [28-30], and Suglp [33,34]. The 
holoenzyme enhances basal as well as activated transcription 
in the reconstituted system, in which 'core' RNA polymerase 
II is unable to support activated transcription [7]. The presence 
of Gal 11 p in the holoenzyme suggested that Gall 1 p contributes 
the activity to stimulate basal transcription i the holoenzyme. 
However, it remains to be clarified whether or not Gall lp is 
also involved in the activity omediate transcriptional enhance- 
ment by activators. 
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